Age-related macular degeneration is a leading cause of blindness and affects over 196 million people worldwide. Despite its prevalence, very little is known about the causes or mechanisms of this ...

An estimated 80 percent of patients with the wet form of macular degeneration are diagnosed too late for effective treatment. Now, there's a new computerized test that can detect it earlier than ever ...

Age-related macular degeneration (AMD) is one the most prevalent eye diseases. In the late stage of the disease, newly formed vessels in the retina alter its structure, which leads to blurry and ...

An Amsler grid, also known as an Amsler grid test, is a tool you can use at home to test your eyes for vision problems. It’s commonly used to test for signs of age-related macular degeneration (AMD).

Assessment of visual function by testing for visual acuity, dark adaptation, contrast sensitivity and evaluation of retinal sensitivity by microperimetry can indicate different stages of disease ...

Ophthalmologists at UC Davis Health used an experimental gene therapy last month to treat a patient with wet age-related macular degeneration, or wet AMD. It was the first time the UC Davis Eye Center ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

A phase 2 clinical trial is underway at Columbia University and NewYork-Presbyterian to test an investigational gene therapy for dry age-related macular degeneration, a progressive, chronic eye ...

Visible Genomics has launched a set of noninvasive genetic tests aimed at assessing the overall risk of developing age-related macular degeneration (AMD) or progressing with the disease. AMD is a ...

By Kamal Choudhury Aug 17 (Reuters) - EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision from causes unrelated to the targeted disease, ...